论文部分内容阅读
目的探讨低分子肝素钙联合丹红注射液治疗高血压脑出血合并肺栓塞的疗效及安全性。方法 2010-06—2016-03收治高血压脑出血合并肺栓塞患者56例,随机分成治疗组和对照组各28例。治疗组采用一般治疗及低分子肝素钙联合丹红注射液治疗,对照组给予一般治疗及低分子肝素钙,治疗21d后评估疗效。结果治疗组有效22例(78.6%),无效5例(17.9%),死亡1例(3.5%)。对照组有效10例(35.7%),无效15例(53.6%),死亡3例(10.7%)。结论低分子肝素钙联合丹红注射液治疗高血压脑出血合并肺栓塞是一种相对安全、有效的方法,值得进一步探讨。
Objective To investigate the efficacy and safety of low molecular weight heparin combined with Danhong injection in the treatment of hypertensive intracerebral hemorrhage complicated with pulmonary embolism. Methods Fifty-six patients with hypertensive intracerebral hemorrhage complicated with pulmonary embolism were randomly divided into treatment group (n = 28) and control group (n = 28). The treatment group with general treatment and low molecular weight heparin combined with Danhong injection treatment, the control group given general treatment and low molecular weight heparin, 21d after treatment to assess the efficacy. Results The treatment group was effective in 22 cases (78.6%), ineffective in 5 cases (17.9%) and death in 1 case (3.5%). The control group was effective in 10 cases (35.7%), invalid in 15 cases (53.6%) and death in 3 cases (10.7%). Conclusion Low molecular weight heparin combined with Danhong injection for hypertensive intracerebral hemorrhage complicated with pulmonary embolism is a relatively safe and effective method, which is worth further study.